...
首页> 外文期刊>Experimental Eye Research >Chitosan oligosaccharides prevented retinal ischemia and reperfusion injury via reduced oxidative stress and inflammation in rats
【24h】

Chitosan oligosaccharides prevented retinal ischemia and reperfusion injury via reduced oxidative stress and inflammation in rats

机译:壳聚糖低聚糖通过减少大鼠的氧化应激和炎症来预防视网膜缺血和再灌注损伤

获取原文
获取原文并翻译 | 示例
           

摘要

The purpose of the present study was to investigate the protective effect and mechanism of chitosan oligonucleotides (COS) on retinal ischemia and reperfusion (I/R) injury. Rats pretreated with PBS, low-dose COS (5 mg/kg), or high-dose COS (10 mg/kg) were subjected to retinal ischemia by increasing their intraocular pressure to 130 mm Hg for 60 min. The protective effect of COS was evaluated by determining the electroretinograms (ERGs), morphology of the retina, and survival of retinal ganglion cells (RGCs). The oxidative damage was determined by imuunohistochemistry and ELISA, respectively. The expressions of inflammatory mediators (TNF-alpha, IL-1 beta, MCP-1, iNOS, ICAM-1) and apoptotic-related proteins (p53, Bax, BcI-2) were quantified by PCR and Western blots. The detection of NF-kappa B p65 in the retina was performed by immunofluorescence. The protein levels of I kappa B and phosphorylated mitogen-activated protein kinases [MAPK; viz. extracellular signal-regulated protein kinases (ERK), c-Jun N-terminal kinases (JNK) and p38] and the NF-kappa B/DNA binding ability were assessed by Western blot analysis and EMSA. We found that pretreatment with COS, especially a high dosage, effectively ameliorated the I/R-induced reduction of the b-wave ratio in ERGs and the retinal thickness and the survival of RGCs at 24 h. COS decreased the expression of inflammatory mediators, p53 and Bax, increasing Bcl-2 expression and thereby reducing retinal oxidative damage and the number of apoptotic cells. More importantly, COS attenuated I kappa B degradation and p65 presence in the retina, thus decreasing NF-kappa B/DNA binding activity after I/R. In addition, COS decreased the phosphorylation levels of JNK and ERK but increased the phosphorylation level of p38. Pretreatment with p38 inhibitor (SB203580) abolished the protective effect of COS on retinal oxidative damage, as indicated by increased retinal 8-OHdG stains, and significantly increased the expression of inflammatory mediators (TNF-alpha, MCP-1, iNOS, ICAM-1) in I/R-injured rats. In conclusion, COS prevented retinal I/R injury through its inhibition of oxidative stress and inflammation. These effects were achieved by blocking the activation of NF-kappa B, JNK, and ERK but promoting the activation of p38 activation. (C) 2014 Elsevier Ltd. All rights reserved.
机译:本研究的目的是研究壳聚糖寡核苷酸(COS)对视网膜缺血和再灌注(I / R)损伤的保护作用和机制。用PBS,低剂量COS(5 mg / kg)或高剂量COS(10 mg / kg)预处理的大鼠通过将其眼压增至130 mm Hg 60分钟进行视网膜缺血。通过确定视网膜电图(ERG),视网膜的形态和视网膜神经节细胞(RGC)的存活率来评估COS的保护作用。分别通过免疫组织化学和ELISA确定氧化损伤。通过PCR和Western印迹定量定量炎性介质(TNF-α,IL-1β,MCP-1,iNOS,ICAM-1)和凋亡相关蛋白(p53,Bax,Bcl-2)的表达。通过免疫荧光检测视网膜中的NF-κBp65。 IκB和磷酸化的丝裂原活化蛋白激酶[MAPK;即Western blot分析和EMSA评估了细胞外信号调节蛋白激酶(ERK),c-Jun N端激酶(JNK)和p38]和NF-κB/ DNA结合能力。我们发现用COS预处理,尤其是高剂量的COS,可以有效地缓解I / R诱导的ERG的b波比降低以及视网膜厚度和24小时RGC的存活率降低。 COS降低了炎症介质p53和Bax的表达,增加了Bcl-2的表达,从而降低了视网膜的氧化损伤和凋亡细胞的数量。更重要的是,COS减弱了IκB降解和视网膜中p65的存在,从而降低了I / R后NF-κB/ DNA的结合活性。此外,COS降低了JNK和ERK的磷酸化水平,但增加了p38的磷酸化水平。用p38抑制剂(SB203580)进行的预处理取消了COS对视网膜氧化损伤的保护作用,如增加的视网膜8-OHdG染色所示,并显着增加了炎症介质(TNF-alpha,MCP-1,iNOS,ICAM-1的表达) )在I / R损伤的大鼠中。总之,COS通过抑制氧化应激和炎症来预防视网膜I / R损伤。这些作用是通过阻断NF-κB,JNK和ERK的激活,但促进p38激活的激活来实现的。 (C)2014 Elsevier Ltd.保留所有权利。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号